Minimally invasive surgery ‘perfectly’ restores hearing

After a brain tumour began growing in to his ear, Denis Paquette was at risk of losing his hearing in both ears – a circumstance that would strip him of his ability to hear his wife’s voice forever. With traditional brain surgery deemed too risky, Dr. Fahad Alkherayf and Dr. Shaun Kilty were challenged to find a safer solution – removing the tumour through his nose.

A life unlike most

Since birth, Denis Paquette, now 66, has been deaf in one ear. It’s clear he has a deep-rooted understanding of the nuances of having such an impairment. After all, it’s all he’s ever known. Holding the phone to his good ear and turning his head while in conversation to better hear someone are habits he was quick to establish.

But in 2016, these little tricks, which he has cultivated throughout his life, started to fail him. Conversations were getting harder to hear and Denis’ wife, Nicole,

Hospital around the world are looking to The Ottawa Hospital tDr. Fahad AlKherayf and Dr. Shaun Kilty standing in an operating room at The Ottawa Hospital.
Hospitals around the world are looking to The Ottawa Hospital to learn about the type of minimally invasive brain surgery performed by Dr. Fahad Alkherayf (right) and Dr. Shaun Kilty.

noticed that Denis was progressively increasing the volume on the television.

“I was beginning to be frustrated because people were talking to me, but I was just getting parts of the conversation,” said Denis.

Journey to diagnosis

Concerned about his hearing, Denis visited his family doctor. He was sent for various hearing tests, each showing that something was wrong. It was then that Denis was referred to Dr. David Schramm, a hearing specialist at The Ottawa Hospital. Dr. Schramm ordered an MRI that revealed Denis had a rare tumour growing in his skull and in to his inner ear. These weren’t the results Denis and Nicole were expecting.

“I didn’t know what to expect, so it was really shocking news,” said Denis.

Denis needed specialized surgery to remove the tumour and required the expertise of neurosurgeon Dr. Fahad Alkherayf and ear, nose, and throat (ENT) specialist Dr. Shaun Kilty.

Due to the complexity of Denis’ diagnosis, Dr. Alkherayf and his team were challenged to remove the tumour without jeopardizing his hearing completely.

“The tumour was growing in his skull and in to his inner ear, putting pressure on his hearing nerve on the good ear. There was a risk he would lose the rest of his hearing,” said Dr. Alkherayf.

“Despite it being a benign lesion, the impact of it was huge.” – Dr. Fahad Alkherayf

Dr. Alkherayf knew that removing the tumour through Denis’ ear could risk permanently damaging what little hearing he had left. With this in mind, Dr. Alkherayf recommended that Denis undergo the newly-available minimally invasive brain surgery. With this technique, his tumour would be removed through his nostrils instead of through his ear.

The risk was high

Traditionally, brain surgery for a case such as Denis’ would take place through the ear and require a large incision through the skull. But with only one good ear to start with, performing brain surgery in this way could permanently and completely impair his hearing.

Not only could Denis lose his hearing, the traditional method of removing such a tumour has a greater risk of complication, a higher chance of infection, and demands a longer recovery period – up to six months. It would also leave a large scar, beginning in front of his ear and extending all the way up and behind it. The thought of undergoing such a procedure alone was nerve-racking.

A new surgery technique

Over the last several years, Dr. Alkherayf has advanced new techniques for removing various types of brain tumours, known as minimally invasive surgery.

Minimally invasive surgery has transformed the way operations are performed by allowing surgeries to be carried out as keyhole procedures, a surgical procedure that provides access to parts of the body without having to make large incisions. This operation is much safer, with risk of infection and recovery time greatly reduced. In many cases, patients are discharged within just a few days of surgery.

“It’s quicker to recover for patients,” said Dr. Kilty. “Because they don’t have to recover from the extensive dissection that traditional approaches [surgeries] require.”

Performing these types of surgeries requires two physicians – a neurosurgeon to remove the tumour and an ENT to provide access to the tumour through the nose and to control the endoscope. Due to the complex nature of these surgeries, Dr. Alkherayf is among a small group willing to perform them. Many are looking to The Ottawa Hospital to learn about this innovative surgery. “We have become one of the top places in Canada for this technique,” said Dr. Alkherayf.

Denis Paquette sitting outside at a table at The Ottawa Hospital.
Denis Paquette’s hearing was restored after receiving minimally invasive brain surgery at The Ottawa Hospital.

“They did a miracle on me”

On July 20, 2016, Denis underwent a five-hour operation during which Dr. Alkherayf and Dr. Kilty were able to successfully access and remove the tumour through his nose. The insertion of a microscopic tube that would travel from the cavity of where the tumour once was to his sinuses which would prevent future buildup of fluid and prevent the chance of reoccurrence.

When he woke up, Denis was astounded that he could hear his wife’s voice. “I woke up and wow,” said Denis, “I could hear!”

Just two days after his surgery, he was discharged.

“They did a miracle on me. They did something fantastic,” said Denis, whose hearing tests have been perfect ever since.

“They did a miracle on me. They did something fantastic.” – Denis Paquette

Thanks to the care Denis received at The Ottawa Hospital and the benefits of minimally invasive surgery, he can now enjoy watching his television shows and conversing with his wife without issue. He no longer fears a life without sound.


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

OCTOBER 26, 2019 OTTAWA, ON – It was a sold-out night at The Ottawa Hospital Gala, presented by First Avenue Investment Counsel, which recognized three innovative researchers. The elegant ballroom of the Westin Hotel was transformed with exquisite décor and a delectable four-course meal, enjoyed by more than 700 guests. It also marked the final gala with Dr. Jack Kitts as President and CEO of The Ottawa Hospital, who will retire in 2020. Guests paid tribute to Dr. Kitts with a standing ovation for his dedication to providing compassionate and world-class care to the Ottawa community through his leadership since 2002.

The Ottawa Hospital Gala celebrated the transformational work of three researchers dedicated to improving care. Congratulations to this year’s three award winners:

Faizan Khan, recipient of the Worton Researcher in Training Award, recognized for his outstanding work on vein blood clots, including a recent British Medical Journal study establishing long-term risks and consequences of clot recurrence.

Dr. Marjorie Brand, recipient of the Chrétien Researcher of the Year Award, recognized for her groundbreaking discovery of how a blood stem cell decides whether to become a red blood cell or a platelet-forming cell.

Dr. Paul Albert, recipient of the Grimes Research Career Achievement Award, recognized for his leadership in Neuroscience, as well as his innovative work on what causes depression and how to treat it.

The Ottawa Hospital is recognized for its world-leading research that attracts internationally recognized scientists and clinicians from around the world. Tim Kluke, President and CEO of The Ottawa Hospital Foundation, emphasized that it’s corporate and individual philanthropic gifts, which make that a reality. “We are privileged to have the support of a generous community which is helping this city advance research to find new hope for patients now and in the future.”

First Avenue Investment Counsel returned as the presenting sponsor of The Ottawa Hospital Gala this year. Kash Pashootan, CEO and Chief Investment Officer at First Avenue Investment Counsel, said it’s a partnership that aligns perfectly. “Innovative research is a necessary investment in the future of health care in our community and we’re proud to fulfill our duty to The Ottawa Hospital. At First Avenue Investment Counsel, we advise families on all aspects of their financial picture including managing their assets to ensure their secure future for them and future generations. Together, we’re laying the building blocks for the future.”

About The Ottawa Hospital: 

The Ottawa Hospital is one of Canada’s largest learning and research hospitals, with more than 1,200 beds, 12,000 staff members and an annual budget of about approximately $1.3 billion.

The focus on learning and research helps to develop new and innovative ways to treat patients and improve care. As a multi-campus hospital affiliated with the University of Ottawa, specialized care is delivered to the eastern Ontario region and the techniques and research discoveries are adopted around the world. The hospital engages the community at all levels to support our vision for better patient care.

From the compassion of our people to the relentless pursuit of new discoveries, The Ottawa Hospital never stops seeking solutions to the most complex patient-centred care. For more information about The Ottawa Hospital, visit ohfoundation.ca.

Local activist donor pledges $500,000 to take on cancer

Gavin Murphy takes pride in describing himself an activist donor.
Gavin Murphy takes pride in describing himself an activist donor.

Gavin Murphy is unwavering when it comes to his desire to maintain a world-class health care system in our city. He’s unwilling to settle for anything less and he doesn’t think anyone in our community should either. Gavin believes each resident needs to play an active role in giving back, and that’s why this self-described “activist” donor is sharing his story – a story he hopes will lead to a cure for cancer.

This New Edinburgh resident has committed $500,000 to support the Radiation Medicine Program at The Ottawa Hospital – it’s what he wants his lasting legacy to be.

While the Ottawa lawyer isn’t looking for public recognition, he’s not shy about sharing the news of his gift as he hopes it will inspire others to do the same. “Scarce government resources requires those in a position to give significant gifts to step forward and support The Ottawa Hospital.” Gavin adds, “By giving serious thought to my philanthropy, I am hoping to help improve discovery and care for our families, friends, and neighbours.”

Gavin’s interest in cutting-edge research is what enticed him to make this tremendous gift to Radiation Medicine Program with the hope that findings will one day be published. He’s excited about the opportunities which lie ahead and the advancements that will be made.

“I want to give this money while I’m still alive. It’s great that people leave money in their estates, I think that’s wonderful but I want to see the fruits of my labour, in my lifetime.” – Gavin Murphy

It’s the fruits of his labour, which will leave his fingerprints on advancements in cancer care to help others in the future. For Gavin, that’s truly exciting. “I like the idea of funding new, innovative technology. It will leave a lasting legacy and this gift is providing the building blocks for future research in this field.”

Donor support is vital to providing doctors and researchers with state-of-the-art tools. It’s also what allows The Ottawa Hospital to be a trailblazer when it comes to transformational advancements. Dr. Miller MacPherson, the Head of Medical Physics at The Ottawa Hospital says, “It’s the generosity of donors like Gavin which allows The Ottawa Hospital to be innovative with new technologies. This support will provide insight for new discoveries and will have an impact on care through research and technology advancements in the field of cancer research.”
Dr. Jason Pantarotto, Head of Radiation Oncology at The Ottawa Hospital, echoes that sentiment, noting that donations to the Radiation Medicine Program are particularly precious. “Despite radiotherapy being a key treatment for nearly 5,000 cancer patients each year in Ottawa, the amount of research dollars available to improve the science is pretty sparse. We are extremely grateful to donors, such as Gavin, who see the benefits of investing in the team and equipment that exists here at The Ottawa Hospital.”

For Gavin, his ultimate goal is to help find a cure for cancer.

“This gift will provide a foundation to greater understanding of cancer and I hope it will help obliterate cancer sometime down the road.”- Gavin Murphy

The reality is The Ottawa Hospital will touch each person in our community in some way. For Gavin, that’s a good reason for not only himself but also for others to step forward. “If people want to be well looked after in a world-class system, we have to ensure a world-class system is maintained.”

The way Gavin sees it, we’ll all need The Ottawa Hospital at some point, and there’s a way for each person in our community to support it. “You need people who are in the position to give, and those who can give smaller amounts, in greater numbers to support the hospital equally.”


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

SEPTEMBER 25, 2019, OTTAWA, ON – September resulted in $2.21 million donated to The Ottawa Hospital as a direct result of community support – solidifying our city’s dedication to ensuring world-class care and research in eastern Ontario. Events including THE RIDE, powered by Mattamy Homes, the President’s Breakfast, golf tournaments, and community-inspired events, all contributed to this excellent example of dedication local residents have to The Ottawa Hospital.

The funds will directly support patient care and research at The Ottawa Hospital. Tim Kluke, President and CEO of The Ottawa Hospital Foundation, said this is a perfect example of a community rallying to ensure doctors, researchers and nurses have the right tools to care for their patients. “Philanthropy takes many forms, and each of these special events embodies the important role The Ottawa Hospital plays in our city. We are grateful for all of the support and we never take it for granted,” said Kluke.

In many cases, community leaders stepped forward to support The Ottawa Hospital and called on their friends and colleagues to do the same. This was the case for Cyril Leeder and Janet McKeage who co-chaired the annual President’s Breakfast held earlier this month.

“Beyond the right tools and equipment, research is fundamental to the advancements in care we are seeing. It’s research which is allowing The Ottawa Hospital to be one of the best health-care centres in the country and it is the generosity of our community which makes that possible,” said Leeder.

McKeage echoed that sentiment, “Together, we have the capability to help push the boundaries when it comes to health care in our city.”

It is community support, which provides critical funds to help purchase equipment not funded by our tax dollars and helps fund the work of a researcher who has dedicated his or her life to finding a cure.

About The Ottawa Hospital:

The Ottawa Hospital is one of Canada’s largest learning and research hospitals, with more than 1,200 beds, 12,000 staff members and an annual budget of about approximately $1.3 billion.

The focus on learning and research helps to develop new and innovative ways to treat patients and improve care. As a multi-campus hospital affiliated with the University of Ottawa, specialized care is delivered to the eastern Ontario region and the techniques and research discoveries are adopted around the world. The hospital engages the community at all levels to support our vision for better patient care.

From the compassion of our people to the relentless pursuit of new discoveries, The Ottawa Hospital never stops seeking solutions to the most complex patient-centred care. For more information about The Ottawa Hospital, visit ohfoundation.ca.

30 years after treatment, leukemia survivor forever grateful

The importance of cancer research is not lost on Robert Noseworthy. He’s reminded of it every time he looks in the mirror.

Robert is a cancer survivor and not a day goes by that he doesn’t appreciate each moment he’s had to share with his two children, who are now adults.

On October 21, 1988, Robert was diagnosed with acute lymphoblastic leukemia—a childhood leukemia. He was living in Montreal at the time with his young family, including Julianne who was 18 months old and his infant son, David.

A grim prognosis

“I was given a 13% chance of survival with 6 months to live. My doctor said it was very unusual for a 30-year-old to have a childhood leukemia,” says Robert.

And so, the cancer journey began for this father of two. It would include numerous rounds of chemotherapy and radiation treatments, which put him into remission, but the journey didn’t end there. “In March 1989, I received a bone marrow transplant from my sister, who was a six-on-six match.”

Thanks to that match, Robert beat the odds. He gives full credit to cancer research as the reason he is alive today. It’s what has driven Robert and his family to become dedicated supporters of cancer research at The Ottawa Hospital. “That is my why. I do my small part and to raise funds for cancer research,” he says.

Robert Noseworthy with his daughter Julianne after they cycled 109 kms during THE RIDE on September 8, 2019.
Robert Noseworthy with his daughter Julianne after they cycled 109 kms during THE RIDE on September 8, 2019.

Time to give back

Giving back has been important to Robert. Each year, his family comes together to cycle and raise funds through THE RIDE, a cycling fundraiser. It’s also been important to him to instill that in his children as they grew up. “I received all this help but now it’s time to give back.”

For Julianne, giving back as a family to The Ottawa Hospital and advancing research has become just as important to her.

“If it wasn’t for cancer research and everything my dad had been through, we wouldn’t be the family that we are today,” says Julianne.

Glancing over at her father, with a smile, Julianne says, “My why is you.”

The way Robert sees it; he is alive because of the investment of others who came before him and he wants to be that hope for someone else battle cancer. “60 years ago someone invested in cancer research. 30 later, I was the beneficiary of that generosity and that’s why I’m here today.”


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

A melanoma diagnosis

The Ottawa Hospital, The Ottawa Hospital Foundation, Ian McDonell
Ian McDonell received immunotherapy in 2017, which erased any trace of his melanoma.

Several years ago, Ian McDonell, a Staff Sergeant with the Ottawa Police and father of three had just lost his father to cancer and his brother was dying of melanoma. Ian’s wife insisted he see his physician to check out a mole on his back. It turned out to be an ulcerated nodular malignant melanoma – an aggressive form of skin cancer.

Ian had surgery to remove it along with a lymph node from his left groin. Several weeks later, he had a lymph node removed from his armpit. Following these surgeries, he had no signs of cancer, but due to his family’s history, Ian was at high risk for relapse.

Sobering news

Ian was feeling well, but during a standard monitoring visit in June 2017, his CT and MRI scans showed sobering news. He had half a dozen tumours in his groin and abdomen, and three more tumours metastasized to his brain. Ian’s cancer was stage 4.

Given the severity of the findings, Dr. Michel Ong at The Ottawa Hospital suggested an aggressive approach – a recently approved immunotherapy treatment.

Unmasking cancer

Scientists have tried for decades to stimulate the immune system to attack cancer cells. But the game changer was the discovery that cancer cells make key molecules, called immune checkpoint proteins, that suppress immune cells and prevent them from attacking the cancer. These immune checkpoint proteins cloak the cancer from the immune system. New drugs called immune checkpoint inhibitors remove this cloak and allow immune cells called T-cells to naturally attack and destroy the cancer.

“The idea of chemotherapy is to kill off cancer directly,” said Dr. Ong. “There are potential side effects, because chemotherapy tries to poison the cancer.

“Immunotherapy does not directly affect the cancer itself. Instead, immunotherapy unmasks the cancer to your immune system by flipping some switches on T-cells, and the body’s own immune system does the rest.” – Dr. Michael Ong

Ian McDonell with his wife Michelle (left), and their daughters Kendra, Macy, and Ainsley, hiking in the Adirondack Mountains in 2019.
Ian McDonell with his wife Michelle (left), and their daughters, hiking in the Adirondack Mountains in 2019.

CyberKnife treatment

Ian started on a combination of two immunotherapies given intravenously in the chemotherapy unit at The Ottawa Hospital’s Cancer Centre. He also underwent CyberKnife radiotherapy treatment where high doses of radiation were directed at his brain tumours. He bravely continued with the second round of immunotherapy, but was so sick, he had to be taken off the treatment and started on steroid medications to slow down the immune system. Ian felt better, but his immunotherapy was on hold.

Shrinking tumours

When Ian began to develop weakness in his face, he worried his cancer was getting worse. It wasn’t. Scans showed one tumour had shrunk from 25 to 10 mm, and another had shrunk from eight to four mm.

Dr. Ong recommended trying a single immunotherapy rather than two, and while the treatment made Ian very sick, it did the trick.

Two months later, the results of a PET scan, MRI, and a CT scan showed that he was tumour-free. All trace of his cancer was gone.

Oncologist Dr. Michael Ong said recent immunotherapies are hugely successful for treating melanoma.
Oncologist Dr. Michael Ong said recent immunotherapies are hugely successful for treating melanoma.

Advances in immunotherapy

When Dr. Ong first met Ian in 2013, options for immunotherapy or targeted chemotherapy weren’t available. Thanks to incredible advances in immunotherapy, there is now hope.

“In the last few years, we’ve gone from having very poor options to having many effective options for melanoma. That’s because cancer therapy continues to develop at a very rapid pace,” said Dr. Ong. “We, at The Ottawa Hospital, are constantly participating in practice-changing clinical trials. The standard of care is constantly changing, as it should. We are continually trying to push the limits of cancer treatment.”

The Ottawa Hospital is a leader in cancer immunotherapy research, both in terms of developing new therapies and in offering experimental treatments to patients. Currently, there are approximately 70 active cancer immunotherapy clinical trials being conducted at the hospital involving nearly 700 patients. The hospital also hosts a national network for immunotherapy research and has developed a number of unique immunotherapies made directly of cells and viruses.

Hope for the future

Because of successful immunotherapy treatments, patients like Ian are now planning a future of living cancer-free.

“When the provincial exams for police services came up, I said, ‘I’m gonna write it, because I’ve got a bit of hope now.’” said Ian.

More importantly, in addition to his career plans, immunotherapy has allowed Ian to plan for the future with his family and a chance to watch his daughters grow up.

Hear more about oncologist Dr. Michael Ong’s work with immunotherapy.


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

Annette ringing the bell of hope following her final cancer treatment.
Annette ringing the bell of hope following her final cancer treatment.

In July 2016, Annette Gibbons had a routine mammogram. She didn’t expect that day would become a pivotal moment in her life and lead to a breast cancer diagnosis. This unexpected news sent her on a journey of treatment, surgery, and uncertainty that required she place her complete trust in her medical team at The Ottawa Hospital for both her physical and emotional well-being.

Following the mammogram, Annette was told that she had dense tissue, which made it difficult to read the results. She wasn’t worried at all when she received a call to schedule another mammogram and ultrasound. But that all changed when her radiologist, Dr. Susan Peddle, gently told her that she thought it was cancer.

Annette, visibly emotional, recalls that fateful day. “Just like that, my life changed and I began my journey.”

The challenges of chemotherapy set in

Annette began chemotherapy treatment under the watchful eye of medical oncologist and scientist Dr. Mark Clemons. “He specializes in the type of cancer I had and is very active in clinical trials and research on leading-edge treatments and practices,” said Annette.

During these early days, she focused solely on getting through the wear and tear of chemotherapy. She recalls that “it’s not anything you can truly prepare for, or understand, until you’re the patient…There was the depressing hair loss, the constant nausea, the searing bone pain and the mind-numbing fatigue. Despite all that, I still tried to keep my spirits up with exercise, a support group, and lots of old movies.”

Research making a difference

During her treatment, Annette participated in several clinical trials led by Dr. Clemons through his innovative REthinking Clinical Trials (REaCT) program. This program engages patients and their loved ones in research every step of the way, from generating ideas to setting priorities to designing studies and sharing results.

One of the studies that Annette participated in has now produced important results that are helping breast cancer patients not only in Ottawa, but around the world.

Trusting her medical team

She also put her complete trust in her medical team and was determined to stay positive. “I knew the stats for survivability were fairly good and I looked forward to resuming my ‘normal life’.”

Little did she know that the next steps – mastectomy and radiation – would be tougher than chemotherapy. The surgery itself and healing had gone well. She credits her amazing surgeon, Dr. Erin Cordeiro, for her compassion and skill.

“She held my hand as I lay in the operating room preparing for the operation to begin.” – Annette Gibbons

“In the end,” Annette says with a little smile on her face, “she gave me, dare I say, the nicest, straightest surgery scar I have ever seen on anyone.”

Sobering news

Annette wouldn’t have the full picture of her cancer prognosis until pathology results came back on her tumour. Several weeks later she received alarming results from Dr. Cordeiro. It was devastating news. “She told me that my tumour was much bigger than first thought. They had found cancer in many of the lymph nodes they removed. I was not expecting that, it was a huge blow.”

As she tried to absorb this news, she sat down with Dr. Clemons a few days later and was dealt another blow. “He gave it to me straight: because of the tumour size and number of lymph nodes affected, my risk of recurrence was high.”

Compassionate care during a dark time

That’s when Annette’s world came crumbling down. She recalls spiralling down into a dark place. “It was very hard to crawl out of this place. But my medical team saw the signs and knew how to help me. My dedicated radiation oncologist, Dr. Jean-Michel Caudrelier, spotted my despair and referred me to the psychosocial oncology program. With the amazing help of Dr. Mamta Gautam, I walked through my deepest fears and came out the other side.”

Annette completed her radiation treatment and then slowly reclaimed her life. But as all cancer patients know, the fear of recurrence can be a constant companion. “I don’t know if that will ever change. But I decided to make it my friend who reminds me to think, not about dying, but about the importance of living while I am alive,” said Annette.

She’s grateful to know the best medical professionals were right here in her hometown when she was diagnosed. As a self-proclaimed “frequent flyer at the hospital”, Annette is proud to say she’s reclaimed her life — including her return to work. “I am myself again, and life is strangely somehow better than it was before.”


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

SEPTEMBER 8, 2019, OTTAWA, ON – 900 cyclists and volunteers came together Sunday and raised $1.07 million to support leading-edge research at The Ottawa Hospital. In ten years, THE RIDE, powered by Mattamy Homes, surpassed the $14 million mark.

Tim Kluke, President and CEO of The Ottawa Hospital Foundation, said the research advancements we’ve seen in the last ten years have been remarkable. “When you look at immunotherapy treatments and CAR-T cell therapy for cancer treatments to stem cell treatments for MS patients, support for research at The Ottawa Hospital has been truly transformational. The dedication we’ve seen from so many riders and volunteers over the past 10 years has been an incredible way to bring our community together.”

“The dedication we’ve seen from so many riders and volunteers over the past 10 years has been an incredible way to bring our community together.”

Tim Kluke, President and CEO of The Ottawa Hospital Foundation

When it comes to inspiring our community to give back to The Ottawa Hospital, Mattamy Homes has been a true leader. Kevin O’Shea is Mattamy Homes Division President, “We not only take great pride being the title sponsor of THE RIDE, but we also participate as a team. It’s a positive way to promote health and wellness in our workplace, as well as, support our leading health care centre in eastern Ontario.”

Making THE RIDE come to life over ten years ago had a great deal to do with Robert Merkley, founder of Merkley Supply Ltd. The team captain of The Brick Peddlers, Merkley had a vision of bringing a phenomenal cycling fundraiser to Ottawa and he, along with Claude DesRosiers and Roger Greenberg, helped make it a reality. “I remember thinking to myself, if I was spearheading this new fundraiser for The Ottawa Hospital, I had better bring together a good, strong team. That’s how The Brick Peddlers came to life. I’m proud to say it’s the largest, most successful and most enthusiastic RIDE team.”

In addition to the 50KM closed route and the 109KM open road route, the 10th edition of THE RIDE also saw the inaugural Alinker one kilometre loop. Dozens of participants joined THE RIDE using the Alinker, a relatively new walk assist bike. These bikes give people with mobility challenges a chance to be a part of this vital fundraiser for research at The Ottawa Hospital – research which could potentially help them one day.

The Ottawa Hospital is one of Canada’s largest learning and research hospitals, with more than 1,200 beds, 12,000 staff members and an annual budget of about approximately $1.3 billion.

Our focus on learning and research helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital affiliated with the University of Ottawa, we deliver specialized care to the eastern Ontario region and our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.

From the compassion of our people to the relentless pursuit of new discoveries, The Ottawa Hospital never stops seeking solutions to the most complex health-care challenges. For more information about The Ottawa Hospital, visit ohfoundation.ca.

It was an unimaginable brain tumour diagnosis that Natasha Lewis never saw coming. It started one morning, in 2016; the mother of three remembers waking up with a strange symptom.

“I looked in the mirror and noticed my tongue was twisting to the left,” recalled Natasha. Her first thought was that she had a stroke, but she was confused by the fact the rest of her body seemed normal.

She went for tests at The Ottawa Hospital  and three days later, her life changed. Natasha was driving when she got the call. Tests revealed a tumour in her brain. “I felt so sick when I heard the news that I had to pull over.”

Diagnosis shatters mom’s world

Natasha Lewis with her husband
Natasha Lewis with her husband, Marvin.

Natasha had a schwannoma tumour on her hypoglossal nerve, which controls the tongue. Schwannomas are rarely found in the brain and even more rarely on that specific nerve. Her mind was racing. “I was only 38 years old, a wife, and mother of three young children.”

When she got home to St. Isidore, east of Ottawa, she sat with her youngest daughter as she relayed the information to her husband. “I had tears falling down my face. I didn’t know what was going to happen.”

All this time she thought she was healthy. “I was losing weight, running, and training for marathons and triathlons.” All she could think about were her three, beautiful, young children. What would this mean for them?

“We’re in the right place. We’re in Canada, we’re close to Ottawa, we’ll get the best care.”

– Marvin Lewis

However, her husband, Marvin, was a pillar of strength. She remembers him saying, “We’re in the right place. We’re in Canada, we’re close to Ottawa, we’ll get the best care.” She adds, “He has never been so right.”

The challenge of non-cancerous brain tumours

Natasha was cared for at The Ottawa Hospital – one of the few hospitals in Canada that could help her because of the complexity of her diagnosis. Dr. Fahad Alkherayf, a world-class skull base surgeon told her the tumour was benign and he would closely monitor her in the months ahead.

Normally, a schwannoma is a tumour that grows in the sheaths of nerves in the peripheral nervous system, or the parts of the nervous system that aren’t in your brain or spinal cord. Schwannomas are usually low-grade tumours, meaning they can often be successfully treated, but they’re still serious and can be life-threatening. It is estimated that in 2021, there will be 27 new primary brain tumours diagnosed every day in Canada. Non-malignant tumours account for almost two-thirds of all primary brain tumours.

Condition deteriorating

Less than a year later, while the tumour had grown only slightly, Natasha’s quality of life was deteriorating.

She was scared to see what was happening with her body. Initially, there was drooling from both sides of her mouth, then Natasha started slurring her words. It was a little embarrassing, but she could handle it. In addition, swallowing became more difficult and her shoulder felt like it was on fire. That’s when she lost the ability to move it and couldn’t use it to work out. Even worse, she couldn’t lift her children.

By May 2018, it was time to operate when the side effects continued to worsen.

Surgeons ready for complex procedure

It was an intricate 10-hour brain surgery. Dr. Alkherayf brought in ear surgeon, Dr. David Schramm, a colleague at The Ottawa Hospital, to assist because of where the tumor was located. Dr. Alkherayf wanted to have another highly-skilled surgeon with him because the tumour was near the ear canal.

Hospital-bound Natasha with Dr. Fahad Alkerayf
Natasha with Dr. Alkherayf

The surgical team accessed her brain through the base of the skull. While minimally invasive surgeries are becoming more common than open surgeries, where the brain is accessed through a more invasive and significant incision, it wasn’t an option for Natasha because there were too many nerves to navigate. With traditional surgery, patients can spend a week recovering in the hospital.  With minimally invasive surgery, they sometimes go home the same day. In Natasha’s case, though complex and intricate, open surgery was the less risky option and she benefitted from the expertise available to her right here in Ottawa.

Dr. Alkherayf knew they likely couldn’t remove all of the tumour because of those surrounding nerves; damaging them meant Natasha might  lose her ability to hear and swallow. While these risks were terrifying for Natasha, Dr. Alkherayf made her feel confident and gave her hope.

“I remember Dr. Alkherayf said there would be another chapter in my life. I held on to those words.”

– Natasha Lewis

Incredibly, her surgeons were able to remove ninety-nine percent of the tumour leaving only a small sliver so they didn’t have to cut the nerves.

Journey continues after remarkable recovery

Following her surgery, Natasha made a remarkable recovery. She has her hearing — it’s a little muffled but she’s told over time it will return to normal. She’s back at work, her speech is back to normal, and she can swallow without difficulty.

This active mom’s recovery has been nothing short of remarkable. Four months post-surgery, Natasha ran the Commander’s challenge at the Army Run. She started training for a marathon and she has the dream of qualifying for the Boston Marathon.

However, in 2019, she received news the tumour had grown back, despite being told the odds of that were low. Natasha was devastated, but her healthcare team would turn to the CyberKnife – a revolutionary piece of equipment that arrived at The Ottawa Hospital in 2010, as a result of donor support.

“At first I was nervous to have the CyberKnife treatment. I had to go by myself because we had no one to watch the kids. However, the staff was very patient, kind, and made you feel warm and safe. I was able to watch a movie and the machine did the work,” recalls Natasha. She would have three, one-hour treatments.

Natasha and her family
Natasha and her family

“I had to go by myself because we had no one to watch the kids. However, the staff was very patient, kind, and made you feel warm and safe.”

– Natasha Lewis

Today, she prays that “Jim,” the name she’s given the tumour, will not come back. While there’s uncertainty over what will happen next, she continues to be active with her running and most importantly, she can run, play with, and hug her three children. “I can hear them laugh and tell me they love me. There is no greater feeling in the world,” smiles Natasha.


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

Stem cell potential

Acute kidney injury affects one in five intensive care patients. A staggering fifty percent of those patients will not survive.

Doing the rounds of the intensive care unit several years ago, nephrologist Dr. Kevin Burns was struck by the number of patients with acute kidney injury. While they had come to intensive care for other serious illnesses, experiencing low blood pressure, shock, infections, blood loss after an operation, or needing to take certain medications, had injured their kidneys.

“Despite ongoing research in this area for over 60 years, there is no treatment,” said Dr. Burns. “Things have been tried to help the kidneys recover and absolutely nothing has worked to date.”

That is until now. Dr. Burns and his fellow researchers at The Ottawa Hospital Kidney Research Centre are uncovering ways to help kidneys recover from injury and to prevent it from happening in the first place.

Dr. Kevin Burns
Nephrologist and senior scientist Dr. Kevin Burns is investigating how stem cells could regenerate kidneys after acute kidney injury.

Chronic kidney disease – preventative research and early treatment

While exciting progress is being made in treating acute kidney injury, researchers at The Ottawa Hospital are also looking into ways to improve detection and treatment of chronic kidney disease.

“If we can catch the disease earlier, treatments will be more effective at preventing or delaying kidney failure. Any way that we can buy time and prevent or delay losing kidney function will be invaluable to patients,” said researcher Dr. Dylan Burger, a world expert laboratory scientist at The Ottawa Hospital’s Kidney Research Centre.

He is developing a diagnostic test that can predict if a person is at risk for developing kidney disease rather than relying on the current tests which show when it is already present, often at an advanced stage.

World-first technique for early detection

In the lab, Dr. Burger’s team looked at what happens at the cellular level when people start to develop kidney disease and identified microparticles as the problem. These are tiny pieces that come off a cell when it’s stressed or injured and are released into the blood or urine causing damage to the kidney.

In response to this finding, the team has developed a technique to count microparticles in urine. This technique, which is still in the research phase, allows any patient’s urine to be tested to accurately determine their risk for developing kidney disease.

The results of this approach have been published and it is now being used in approximately 20 different labs around the world. A standardized technique is being developed so that any lab in the world can use the same diagnostic test for patients.

Dr. Dylan Burger with student Ozgun Varol
World expert laboratory scientist Dr. Dylan Burger watches student researcher Ozgun Varol.

World-class expertise

These studies are only part of the kidney research taking place at the Ottawa Hospital. As one of Canada’s largest health research centres, researchers and clinicians have tremendous opportunity to learn from each other and work collaboratively to bring treatments from the lab to the bedside.

The expertise of these scientists, the quality of their kidney research, and the number of publications is attracting researchers from around the world. This level of excellence and a resolve to remain at the forefront of research and discovery will directly translate into improved treatment and outcomes for patients.

To learn more about the leading research of The Ottawa Hospital and the life-changing innovations that are improving patient lives, please click here.


The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

Important Notice - Canada Post operations have resumed, but mail delivery may still be affected. For more details on online and in-person donation options, please click here.